Lucid Diagnostics (LUCD) FCF Margin Growth (1y) (2022 - 2026)
Lucid Diagnostics (LUCD) FCF Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1,716.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2,833.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2,811.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -125.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 | 56,928.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56,928.00 |
| Dec 31, 2025 | -1,548.00 |
| Sep 30, 2025 | -3,075.00 |
| Jun 30, 2025 | 29,735.00 |
| Mar 31, 2025 | -25,673.00 |
| Dec 31, 2024 | 13,487.00 |
| Sep 30, 2024 | 25,328.00 |
| Jun 30, 2024 | 318,646.00 |
| Mar 31, 2024 | 34,028.00 |
| Dec 31, 2023 | 284,227.00 |
| Sep 30, 2023 | 854,433.00 |
| Mar 31, 2023 | 153,417.00 |
| Dec 31, 2022 | -23,479.00 |
| Sep 30, 2022 | -856,079.00 |